Skip to main content

Navigation group

Type at least 3 characters
479 articles

Articles

Study Protocol

Published on 23 Jul 2020

Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol

in Molecular Psychiatry

  • Kristin Köhler-Forsberg
  • Anders Jorgensen
  • Vibeke H. Dam
  • Dea Siggaard Stenbæk
  • Patrick M. Fisher
  • Cheng-Teng Ip
  • Melanie Ganz
  • Henrik Enghusen Poulsen
  • Annamaria Giraldi
  • Brice Ozenne
Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.00641
  • 24,293 views
  • 42 citations